Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy
Clinical trial NCT05666804 · COMPLETED
Trial details
- NCT number
- NCT05666804
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-06
- Primary completion
- 2025-09-10
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.